Financial SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) byJosh SandbergApril 10, 2024
Extremities Financial Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 byTim AllenApril 4, 2024
Spine BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergFebruary 5, 2024
Financial Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results byJosh SandbergJanuary 10, 2024
Financial SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023 byJosh SandbergJanuary 10, 2024
Financial Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results byJosh SandbergJanuary 9, 2024
Financial OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023 byJosh SandbergJanuary 8, 2024
Financial ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance byJosh SandbergJanuary 8, 2024
Financial Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 byJosh SandbergJanuary 8, 2024
Financial ATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance byJosh SandbergOctober 16, 2023
